BASF India Adjusts Valuation Grade Amid Competitive Agrochemical Market Dynamics
BASF India, a midcap in the Pesticides & Agrochemicals sector, has adjusted its valuation based on financial metrics, including a price-to-earnings ratio of 41.29. The company has delivered strong long-term returns but faces challenges in the short term, reflecting the competitive landscape within the industry.
BASF India, a midcap player in the Pesticides & Agrochemicals sector, has recently undergone a valuation adjustment, reflecting its current financial metrics and market position. The company's price-to-earnings ratio stands at 41.29, while its price-to-book value is noted at 5.56. Other key metrics include an EV to EBIT ratio of 33.67 and an EV to EBITDA ratio of 25.65, indicating a robust valuation relative to its earnings potential.In terms of returns, BASF India has shown a notable performance over the long term, with a three-year return of 83.59%, significantly outperforming the Sensex, which recorded a 56.33% return in the same period. However, the company has faced challenges in the shorter term, with a year-to-date return of -19.35%, contrasting with the Sensex's positive growth of 5.62%.
When compared to its peers, BASF India maintains a competitive position, although some competitors exhibit higher valuation metrics. For instance, Anupam Rasayan is positioned at a higher valuation level, while Dhanuka Agritech and Sharda Cropchem present varied metrics that highlight the competitive landscape within the industry. This evaluation adjustment underscores the dynamic nature of the market and the importance of ongoing performance analysis.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
